NDC 70677-0153-01 - Ibuprofen Oral
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70677-0153
- Requested NDC
- 70677-0153-01
- Package NDCs from labels
- 70677-0153-1, 70677-0153-01
- Manufacturer
- Strategic Sourcing Services | AptaPharma Inc.
- Effective date
- 2022-08-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ibuprofen Oral Suspension USP, 100 mg/5 mL (OTC) | Strategic Sourcing Services | AptaPharma Inc. | 2022-08-10 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70677-0153-1 | Ibuprofen Oral | 118 mL in 1 BOTTLE | SUSPENSION | 118 | 1 | |
| 70677-0153-1 | Ibuprofen Oral | 1 in 1 CARTON | SUSPENSION | 1 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70677-0153 | IBUPROFEN ORAL (IBUPROFEN ORAL) SUSPENSION [STRATEGIC SOURCING SERVICES] | 1 | Current NDC, Legacy NDC, 2 package rows | 20220811_a3062142-db0e-4758-a762-2b2bb05670b1.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70677-0153-1 | ML - Milliliter | 70677-0153 | b4e8be0e-e5f7-4a79-9455-79aaa2fb6e4f | 1 | 2023-02-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Medics Choice Fresh and Soothe | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN | KC Pharmaceuticals, Inc. | 3bc03d54-6b31-5921-e063-6294a90af599 | 2025-08-01 | Warnings | PDC6A3C0OX K679OBS311 |
| Childrens Ibuprofen Oral Suspension | IBUPROFEN | PAI Holdings, LLC dba PAI Pharma | c26cefe0-182a-4b03-baeb-b3eb2e0e2267 | 2025-08-01 | Warnings | 197803 WK2XYI10QM |
| Ibuprofen and famotidine | IBUPROFEN AND FAMOTIDINE | Preferred Pharmaceuticals Inc. | e2f29ca9-9ec8-4b82-8c80-8628d9e3ab2f | 2025-08-01 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Acetaminophen, Ibuprofen | ACETAMINOPHEN, IBUPROFEN | GLENMARK THERAPEUTICS INC., USA | 57a8dc2b-a3bc-49fa-b605-2330155bdbff | 2025-07-31 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | 0e95aab9-3a7c-49c3-b8df-f66d6f31aee0 | 2025-07-31 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Rite Aid Corporation | 47657d95-4a54-49c2-8273-86b413b8f41e | 2025-07-30 | Warnings | WK2XYI10QM |
| Systane Ultra | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 0537c23a-15f7-be64-1231-a6c93468e9a8 | 2025-07-30 | Warnings | 6DC9Q167V3 |
| Systane | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 1d679d0f-cec2-a644-79cd-079607254bb9 | 2025-07-30 | Warnings | 6DC9Q167V3 |
| Systane Ultra Preservative Free | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 751fb85f-6683-4b0a-a650-324d4a74c5de | 2025-07-30 | Warnings | 6DC9Q167V3 |
| Systane COMPLETE PF | PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 99b63d62-1cf0-4f28-8760-773917c2538a | 2025-07-29 | Warnings | 6DC9Q167V3 |
| Doctor Butler Hemorrhoid and Fissure Advanced Formula | GLYCERIN 37.5%, LANOLIN 12.5%, LIDOCAINE 4%, ZINC OXIDE 5% | Beyond Health, PA | d2a769e2-afd0-aed2-e053-2995a90ad429 | 2025-07-23 | Warnings | PDC6A3C0OX |
| Childrens Ibuprofen | IBUPROFEN | Publix Super Markets Inc | 54ae0273-4d8d-4c3b-85ff-675ba96f00de | 2025-07-22 | Warnings | WK2XYI10QM |
| ADVIL SINUS CONGESTION AND PAIN | IBUPROFEN, PHENYLEPHRINE HYDROCHLORIDE | Haleon US Holdings LLC | b1e29c19-fe03-4d2b-b966-0adf4eb4b4cf | 2025-07-22 | Warnings | WK2XYI10QM |
| Cold Sore Fast-Acting Pain Relief | GLYCERIN AND LIDOCAINE | Blistex Inc. | c7511322-dd6c-441c-bf7d-ad4f0c14956a | 2025-07-22 | Warnings | PDC6A3C0OX |
| Cureforte Breath Reset | MOUTH SPRAY | STEEL CITY HEALTH PRIVATE LIMITED | 38ddf1a7-29ab-cb8d-e063-6294a90ad34c | 2025-07-21 | Warnings | PDC6A3C0OX |
| INFANTS IBUPROFEN | IBUPROFEN | Safeway | 6fed7c65-69a3-4899-a85d-23ea95f571a4 | 2025-07-21 | Warnings | WK2XYI10QM |
| GoodSense Hemorrhoidal Pain Relief | GLYCERIN, LIDOCAINE, PETROLATUM, PHENYLEPHRINE HCL | Perrigo Direct, Inc | 2e5f699d-45e8-6451-e063-6394a90a8ad8 | 2025-07-20 | Warnings | PDC6A3C0OX |
| Ibuprofen | IBUPROFEN | SOLA Pharmaceuticals, LLC | 44fb0842-c34e-477e-96df-350cd5d6800e | 2025-07-20 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Chain Drug Consortium | 6c593a9c-680e-4645-8e8f-d8d044c92ca1 | 2025-07-18 | Warnings | WK2XYI10QM |
| Dual Action | ACETAMINOPHEN AND IBUPROFEN (NSAID) TABLETS, 250 MG/ 125 MG | Dr. Reddy's Laboratories Inc | c8a8a18a-6766-37a9-d0f0-f9380fb5b0e8 | 2025-07-18 | Warnings | WK2XYI10QM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.